Evolent Health Stock Today
| EVH Stock | USD 11.25 0.34 2.93% |
Performance0 of 100
| Odds Of DistressLess than 38
|
Evolent Health is trading at 11.25 as of the 25th of November 2024. This is a 2.93 percent decrease since the beginning of the trading day. The stock's open price was 11.59. Evolent Health has about a 38 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Note, on May 29, 2020, Representative Greg Gianforte of US Congress acquired $50k to $100k worth of Evolent Health's common stock.
Business Domain Health Care Equipment & Services | IPO Date 5th of June 2015 | Category Healthcare | Classification Health Care |
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. The company was founded in 2011 and is headquartered in Arlington, Virginia. The company has 115.03 M outstanding shares of which 12.49 M shares are currently shorted by investors with about 7.7 days to cover. More on Evolent Health
Moving together with Evolent Stock
Moving against Evolent Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Evolent Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Dan McCarthy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, NYSE Composite, Health Care, Health Care Technology, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsEvolent Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Evolent Health's financial leverage. It provides some insight into what part of Evolent Health's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evolent Health (EVH) is traded on New York Stock Exchange in USA. It is located in 1812 N. Moore Street, Arlington, VA, United States, 22209 and employs 4,700 people. Evolent Health is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 1.29 B. Evolent Health runs under Health Care Technology sector within Health Care industry. The entity has 115.03 M outstanding shares of which 12.49 M shares are currently shorted by investors with about 7.7 days to cover.
Evolent Health has about 188.2 M in cash with 142.58 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.57.
Check Evolent Health Probability Of Bankruptcy
Ownership AllocationThe majority of Evolent Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Evolent Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Evolent Health. Please pay attention to any change in the institutional holdings of Evolent Health as this could imply that something significant has changed or is about to change at the company. Please note that on May 29, 2020, Representative Greg Gianforte of US Congress acquired $50k to $100k worth of Evolent Health's common stock.
Check Evolent Ownership Details
Evolent Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| State Street Corp | 2024-06-30 | 2.7 M | |
| Bellevue Group Ag | 2024-09-03 | 2.7 M | |
| Orbimed Advisors, Llc | 2024-06-30 | 2.6 M | |
| Blair William & Co | 2024-06-30 | 2.6 M | |
| Geode Capital Management, Llc | 2024-09-30 | 2.5 M | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 2.4 M | |
| First Light Asset Management, Llc | 2024-09-30 | 2.3 M | |
| Bank Of New York Mellon Corp | 2024-06-30 | 2 M | |
| Holocene Advisors, Lp | 2024-09-30 | 2 M | |
| Wellington Management Company Llp | 2024-06-30 | 11.2 M | |
| Vanguard Group Inc | 2024-09-30 | 10.9 M |
Evolent Health Historical Income Statement
Evolent Stock Against Markets
Evolent Health Corporate Directors
| Bridget Duffy | Independent Director | Profile | |
| Bruce Felt | Independent Director | Profile | |
| Cheryl Scott | Lead Independent Director | Profile | |
| David Farner | Director | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 21.554 | Quarterly Revenue Growth 0.216 | Return On Assets 0.0073 | Return On Equity (0.06) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.